BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com
BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com
Analysts at StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research report issued to clients and investors on Saturday. The brokerage set a "sell" rating on the medical technology company's stock.
斯托克新聞網的分析師在週六發佈給客户和投資者的一份研究報告中開始報道納斯達克(BIOLASE:BIOL-GET Rating)的股票。該經紀公司對這家醫療技術公司的股票設定了“賣出”評級。
A number of other brokerages have also recently weighed in on BIOL. Benchmark reduced their price target on shares of BIOLASE to $7.00 in a research report on Wednesday, November 16th. Maxim Group reduced their price target on shares of BIOLASE from $10.00 to $5.00 in a research report on Friday, November 11th. Finally, Ascendiant Capital Markets reduced their price target on shares of BIOLASE to $14.00 in a research report on Wednesday, November 16th.
其他一些券商最近也加入了Biol的行列。Benchmark在11月16日星期三的一份研究報告中將BIOLASE的股票目標價下調至7.00美元。Maxim Group在11月11日星期五的一份研究報告中將BIOLASE的股票目標價從10.00美元下調至5.00美元。最後,Ascaldiant Capital Markets在11月16日星期三的一份研究報告中將BIOLASE的股票目標價下調至14.00美元。
BIOLASE Price Performance
Biolase價格表現
BIOL opened at $0.84 on Friday. The company has a fifty day moving average price of $1.83 and a two-hundred day moving average price of $3.41. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.27 and a current ratio of 2.46. BIOLASE has a 52 week low of $0.76 and a 52 week high of $13.83. The firm has a market capitalization of $6.00 million, a PE ratio of -0.24 and a beta of 1.34.
Biol上週五開盤報0.84美元。該公司的50日移動均線價格為1.83美元,200日移動均線價格為3.41美元。該公司的負債權益比率為0.92,速動比率為1.27,流動比率為2.46。Biolase的52周低點為0.76美元,52周高位為13.83美元。該公司市值為600萬美元,市盈率為-0.24,貝塔係數為1.34。
Institutional Investors Weigh In On BIOLASE
機構投資者看好BIOLASE
BIOLASE Company Profile
Biolase公司簡介
(Get Rating)
(獲取評級)
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications.
Biolase公司與其子公司一起,在美國和國際上為牙科醫生及其患者開發、製造、營銷和銷售激光系統。它的牙科激光系統允許牙醫、牙周病醫生、牙髓醫生、口腔外科醫生和其他牙科專家執行一系列微創牙科手術,如美容、修復和複雜的外科應用。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on BIOLASE (BIOL)
- Intel is a Sleeping Giant Ready to Awaken
- Why CSL Ltd Stock Could Be Worth a Look
- MarketBeat: Week in Review 11/28 – 12/02
- Okta Inc Celebrates Earnings Beat But Can They Sustain the Boost?
- Institutions Are Buying Ambarella, Should You?
- 免費獲取StockNews.com關於BIOLASE的研究報告(Biol)
- 英特爾是一個沉睡的巨人,準備醒來
- 為什麼CSL有限公司的股票值得一看
- MarketBeat:回顧一週11/28-12/02
- Okta Inc.慶祝收益節節攀升,但他們能持續這種提振嗎?
- 機構正在購買安巴雷拉,你應該嗎?
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.
接受《BIOLASE日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對BIOLASE和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。